Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Recurrent implantation failure (RIF) is considered a tough problem in assisted reproductive technology (ART) without effective treatments. The effect of low molecular weight heparin (LMWH) in pregnancy outcomes is controversial. In addition, there are few reports on the role of LMWH in population with RIF performing freeze-thaw embryo transfer (FET) cycles. The purpose of this study is to evaluate the effect of LMWH on pregnancy outcomes in women with FET cycles.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| LMWH group | the LMWH group received injections of 4100 IU/d LMWH from the day of transplant |
| |
| Control group | the control group received the routine luteal support protocol (without LMWH use) |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Low Molecular Weight Heparine | Drug | the LMWH group received injections of 4100 IU/d LMWH from the day of transplant |
|
| Measure | Description | Time Frame |
|---|---|---|
| Ongoing pregnancy rate | The number of ongoing pregnancies divided by the number of women who received a transfer | from transplantation to delivery (assessed up to 40 weeks of gestation) |
| Measure | Description | Time Frame |
|---|---|---|
| biochemical pregnancy rate | The number of biochemical pregnancy cycles divided by the number of transplantation cycles | from transplantation to delivery (assessed up to 40 weeks of gestation) |
| clinical pregnancy rate |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
The study analyzed the data from the hospital electronic database for patients undergoing FET between January, 2021 and November, 2024, a total of 392 transplant cycles, who undergoing at least two IVF or ICSI cycles from the Second Hospital of Shandong University.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Second Hospital of Shandong University | Jinan | Shandong | China |
The investigators fully acknowledge the significance of data sharing as stipulated by SCI journals. However, owing to the policies and confidentiality agreements adhered to in our laboratory, the investigators regretfully cannot furnish the raw data. Nevertheless, the investigators have meticulously presented a comprehensive account of the experimental design, analysis, results, and the procedures employed for data analysis and processing.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The number of clinical pregnancies divided by the number of women who received a transfer
| from transplantation to delivery (assessed up to 40 weeks of gestation) |
| ectopic pregnancy rate | The number of ectopic pregnancies divided by the number of women who received a transfer | from transplantation to delivery (assessed up to 40 weeks of gestation) |
| Miscarriage rate | The number of miscarriages divided by the number of clinical pregnancies | from transplantation to delivery (assessed up to 40 weeks of gestation) |